| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Advances from customers | - | -84,899 |
| Net cash used in operating activities | -3,729 | 233,258 |
| Purchases of property and equipment | 58,870 | 58,259 |
| Advances for intangible assets | 72,614 | 32,627 |
| Net cash used in investing activities | -131,484 | -90,886 |
| Payments of line of credit | 474,932 | 1,092,893 |
| Borrowings and interest from related party | 253,497 | 297,673 |
| Proceeds from lines of credit | - | 695,999 |
| Net cash (used in) provided by financing activities | -221,435 | -99,221 |
| Effect of exchange rate changes on cash | -2,606 | -44,998 |
| Net increase in cash and cash equivalents | -359,254 | -1,847 |
| Cash and cash equivalents at beginning of period | 626,879 | - |
| Cash and cash equivalents at end of period | 267,625 | - |
CHINA PHARMA HOLDINGS, INC. (CPHI)
CHINA PHARMA HOLDINGS, INC. (CPHI)